SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE

Details for Australian Patent Application No. 2002346077 (hide)

Owner PENWEST PHARMACEUTICALS COMPANY

Inventors BAICHWAL, Anand, R.; KAO, HuaiHung; MCCALL, Troy, W.

Pub. Number AU-A-2002346077

PCT Number PCT/US02/21403

PCT Pub. Number WO2003/004033

Priority 60/329,352 15.10.01 US; 60/329,426 15.10.01 US; 60/303,357 06.07.01 US

Filing date 3 July 2002

Wipo publication date 21 January 2003

International Classifications

A61K 031/485 - Morphinan derivatives, e.g. morphine, codeine

A61K 009/00 Medicinal preparations characterised by special physical form

A61P 025/04 Drugs for disorders of the nervous system

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 60/329,352 15.10.01 US; 60/329,426 15.10.01 US; 60/303,357 06.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002346077

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346078-EVALUATION AND ADJUSTMENT OF LASER LOSSES ACCORDING TO VOLTAGE ACROSS GAIN MEDIUM

2002346076-METHODS AND APPARATUS FOR EXTENDING THE TRANSMISSION RANGE OF UTOPIA INTERFACES AND UTOPIA PACKET INTERFACES